Uusi tutkimus: COVID-19-rokotteen tehosterokotteet ovat 90 % tehokkaita Omicronia vastaan

The first study looked at hospitalizations and emergency room and urgent care center visits in 10 states, from August to this month.

It found vaccine effectiveness was best after three doses of the Pfizer or Moderna vaccines in preventing COVID-19-associated emergency department and urgent care visits.

Protection dropped from 94 percent during the Delta wave to 82 percent during the Omicron Aalto.

Protection from just two doses was lower, especially if six months had passed since the second dose.

Officials have stressed the goal of preventing not just infection but severe disease.

The second study focused on COVID-19 case and death rates in 25 states from the beginning of April through the end of December.

People who were boosted had the highest protection against coronavirus infection, both during the time Delta was dominant and also when Omicron otti vallan.

Those two articles were published online by the Centers for Disease Control and Prevention.

MITÄ TÄSTÄ ARTIKKELASTA OTTAA POIS:

  • The second study focused on COVID-19 case and death rates in 25 states from the beginning of April through the end of December.
  • It found vaccine effectiveness was best after three doses of the Pfizer or Moderna vaccines in preventing COVID-19-associated emergency department and urgent care visits.
  • People who were boosted had the highest protection against coronavirus infection, both during the time Delta was dominant and also when Omicron was taking over.

Kirjailijasta

Harry Johnsonin avatar

Harry Johnson

Harry Johnson on toiminut tehtävien toimittajana eTurboNews yli 20 vuoden ajan. Hän asuu Honolulussa Havaijilla ja on kotoisin Euroopasta. Hän nauttii uutisten kirjoittamisesta ja käsittelemisestä.

Tilaa
Ilmoita
vieras
0 Kommentit
Sisäiset palautteet
Näytä kaikki kommentit
0
Haluaisitko ajatuksiasi, kommentoi.x
Jakaa...